JPRN-jRCT2080220365未知2 期
Phase II clinical study on combination of oxaliplatin (L-OHP) and S-1 in advanced / recurrent gastric cancer untreated with chemotherapy
适应症
试验速览
- 阶段
- 2 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Gastric cancer confirmed by histological diagnosis or cytologic diagnosis
- •- Unresectable advanced / recurrent gastric cancer
- •- Age of 20 years or older
- •- Not pretreated with chemotherapy drugs, immunotherapeutic drugs, or radiation therapy
- •- ECOG Performance Status 0 to 2
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Phase II trial of second line therapy with Oxaliplatin and Pemetrexed in patients with advanced pancreatic cancer - Pemetrexed_OxaliplatinoAdvanced pancreatic cancer patientsMedDRA version: 14.1Level: PTClassification code 10059326Term: Pancreatic carcinoma stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2006-001272-21-ITAZIENDA OSPEDALIERO-UNIVERSITARIA S. MARIA DELLA MISERICORDIA DI UDINE
已完成
1 期
Phase I/II study of the combination of Oxaliplatin and S-1 in patients with advanced/recurrent colorectal cancerunresectable advanced/recurrent colorectal cancerJPRN-C000000443Outpatient Oncology Unit Kyoto University Hospital42
已完成
2 期
Phase II trial of combination therapy with oxaliplatin and capecitabine in patients with advanced oesophageal cancerCancerISRCTN07447845Erasmus Medical Centre (The Netherlands)51
进行中（未招募）
不适用
Phase I/II study of oxaliplatin combined with melphalan in isolated hepatic perfusion for the treatment of liver metastases. - Oxaliplatin combined with melphalan in IHP.EUCTR2006-005088-25-NLeiden University Medical Center
尚未招募
不适用
Phase I/II study of oxaliplatin combined with melphalan in isolated hepatic perfusion for the treatment of liver metastases.liver metastasessecondary liver tumours10017991NL-OMON30309eids Universitair Medisch Centrum60